ArticleMedical oncology (Northwood, London, England)2018

The critical role of comorbidities and polypharmacy in lower risk myelodysplastic patients: is there any difference between countries?

Priscila da Silva Mendonça et al.PubMed ↗Publisher ↗

No numbers read from the abstract.